Four horses were inoculated with Ehrlichia risticii contained in either infected murine P388 D1 cells or heparinized blood from an infected horse. All 4 horses produced serum antibody, plasma antigen, and clinical signs of the disease. An enzyme-linked immunosorbent assay was used to detect antibody in the serum and was also used in conjunction with an anti-E. risticii monoclonal antibody to detect antigenemia. These laboratory and clinical findings were correlated to determine the efficiency of the antigen detection method for discerning E. risticii infection.
tibody to detect ehrlichial antigens in blood of infected horses was developed. Results of this assay were compared with occurrence of serum anti-E. risticii IgM and IgG antibodies detected by ELISA and serum IgG antibodies detected by IFA.
Materials and methods
Experimental animals. Four healthy adult horses that lacked hematologic abnormalities and serum antibodies to E. equi and E. risticii by IFA tests were housed in indoor screened stalls and maintained on a diet of commercial feed, hay, and water. One horse was inoculated intravenously with 55 ml heparinized blood from an E. risticii-infected horse, and 3 horses were inoculated with a 5-day culture of washed 1 x 10 6 E. risticii-infected murine P388 D1 cells contained in 10 ml of phosphate-buffered saline (PBS). Clinical signs and rectal temperature were monitored daily. Serum samples for antibody detection and ethylenediaminetetraacetic acid whole blood samples for plasma used in antigen detection were collected from the jugular vein twice weekly. The horses were euthanized when the signs of the disease became severe.
Anti-E. risticii monoclonal antibody. A murine anti-E. risticii monoclonal antibody produced in our laboratories was used in this study (K. McDonough et al., unpublished) . Balb/C mice were injected intraperitoneally (IP) with 1 x 10 6 E. risticii-infected P388 D1 murine cells 2 times at 2wk intervals, and blood samples were taken 2 wk after the second injection to determine E. risticii titers by IFA. Mice with titers of 160-320 were inoculated again with infected P388 D1 cells, and nucleated cells were harvested from their spleens 3 days later. The spleen cells were fused with SP2/0 cells. 4 The resulting hybridoma cells were cloned by limiting dilution, and the cells were frozen. Hybridoma cells were also injected IP into Balb/C mice to produce monoclonal antibodies in ascites fluid. The monoclonal antibody that was selected was specific for E. risticii by IFA and ELISA. The specificity of this antibody against E. risticii proteins was demonstrated by Western blot analysis, and its isotype determined as IgG by immunodiffusion. Antigen detection by ELISA. Equine serum, plasma, and plasma heated at 57 C for 1 hr were used as test specimens. Control samples included similar specimens from 2 horses with E. equi infection and 2 horses that were seronegative by IFA and ELISA. Fifty microliters of 1:2, 1:5 and 1:10 dilutions of specimen in coating buffer (pH 9.6) were added to wells of ELISA plates. a The plates were incubated 3.5 hr at 37 C and then washed 3 times for 5 min in a Tween 20/ saline solution. Fifty microliters of the anti-E. risticii murine monoclonal antibody (either 1:10 dilution of supernatant or 1:100 dilution of ascites fluid in serum diluent) was added to wells and incubated at 37 C for 1 hr. The wash step was repeated, and 100 µ1 of 1:200 dilution of peroxidase-labeled goat anti-mouse IgG (H & L chain) b was added to wells and incubated 1 hr at 37 C. The wash step was repeated, and 100 µl of peroxidase substrate b diluted 1:1 in hydrogen peroxide at 37 C was added. The plate was agitated for 15 min and read using an ELISA plate reader a at 410 nm test and 490 nm reference, after an air blank step. Optical density readings of 0.20 above the negative control at the same dilution were considered positive for ehrlichial antigen, and the reciprocal of that dilution was reported as the titer.
Antibody detection by ELISA. To prepare the test antigen, E. risticii was harvested from infected P388 D1 murine cells and purified by column chromatography using a size exclusion bead as previously described? The isolated protein was diluted in coating buffer to a concentration of 1.0 µg/ml as verified by a protein assay. One hundred microliters of antigen solution were added to wells of ELISA plates a and incubated 4 hr at 37 C. The plates were washed 3 times for 5 min each in a Tween 20/saline solution. The blocking solution consisted of 100 µ1 5% nonfat milk in ELISA PBS (EPBS) added to each well and incubated for 1 hr at 37 C. Following another wash, 100 µ1 of test specimen was added. The plates were incubated 1 hr at 37 C and then washed. One hundred microliters of 1:100 peroxidase-labeled goat anti-horse IgG (H & L chain) b or IgM (p chain) b containing 5% heat-inactivated goat serum in EPBS was added and incubated for 1 hr at 37 C. Plates were washed 3 times for 5 min each, and 100 µ1 of peroxidase substrate b diluted 1:1 in hydrogen peroxide was added. The plates were agitated 10-15 min and read using an ELISA plate reader a at 410 nm test and 490 nm reference. Optical density readings of 0.20 above the negative control at the same dilution were considered positive.
Antibody detection by IFA. This assay is similar to that previously described, 7 except that E. risticii antigen was propagated in A72 canine tumor cells, rather than in P388 D1 murine cells, to decrease nonspecific fluorescence (Gaunt SD, Corstvet RE, Kams PA: 1987, Abstr Conf Res Workers Anim Dis #214).
Results
Two of 4 horses developed clinical signs typical of Potomac horse fever after the initial inoculation with E. risticii. Horse 0247 was inoculated with E. risticii infected P388 D1 cells and horse 3PF was inoculated with 55 ml of E. risticii infected heparinized blood taken from horse 0247 15 days after inoculation. The other two horses 6948 and piebald developed signs after the second inoculation with E. risticii-infected P388 D1 cells, which were injected 16 and 44 days respectively, after the first inoculation. Failure of the initial inoculation was believed to be due to subcutaneous injection of part or all of the infected tissue culture.
Fever was initially detected in affected horses at 7-19 days postinoculation (DPI), and diarrhea was observed at 7-20 DPI. All experimental horses were euthanized at 13-28 DPI after the onset of acute laminitis or severe diarrhea.
Ehrlichial antigen was detected in heat-inactivated plasma of all E. risticii-infected horses (Tables l-4 ). Non-heat-inactivated plasma gave variable results for detection of antigen. Increased titers of ehrlichial antigen in plasma occurred initially at 3-7 DPI in all 4 horses. In the 2 horses that required only 1 injection of E. risticii to produce disease, the plasma antigen titer was consistently detected throughout the course of infection. Horses piebald and 6948, which were injected twice to produce disease, had detectable ehrlichial antigen at 3-5 DPI after the first injection. This titer decreased to undetectable levels in piebald but remained detectable in 6948 through 11 DPI without clinical signs. After the second injection, E. risticii antigen was detected in piebald; however in horse 6948, antigen was detected only at 2 DPI. These 2 horses developed clinical signs after the second injection.
Ehrlichial antigen was not detected in the serum of these E. risticii-infected horses nor in serum or plasma specimens collected serially from 2 horses with active E. equi infection or from noninfected horses.
Serum anti-E. risticii IgG was detected by ELISA in all 4 infected horses by 5-14 DPI, and IgM titers increased in all horses beginning at 7-12 DPI. The IgG response preceded the IgM titers in 2 horses and was detected on the same day as IgM increase in 2 horses (Tables 1-4). In 3 horses, detection of positive IFA titers occurred on the same day or later in comparison with detectable ELISA IgG titers. The maximal levels of serum antibody detected for the ELISA IgG and IgM and IFA IgG were similar in all horses.
Discussion
An antigen-detecting ELISA utilizing an anti-E. risticii monoclonal antibody demonstrated the presence of ehrlichial antigen in blood samples from experimentally infected horses. Ehrlichial antigen was de- tected in plasma, not serum, suggesting that the antigens recognized by the monoclonal antibody are associated with cells or proteins removed from the fluid phase of serum by the clotting process. Non-heat-inactivated plasma gave variable antigen detection results, possibly because of destruction of antigen by enzymes in the plasma. Plasma was the preferred specimen in another antigen detection ELISA used to identify a malarial antigen in mice. 8 Comparison of the pattern and concentration of ehrlichial antigens in serum and plasma from infected horses by immunoblot analysis would elucidate the difference in these specimens. The antigen-detecting ELISA did not detect any ehrlichial antigen in blood of horses with active E. equi infection (R. E. Corstvet, unpublished data), indicating lack of cross-reactivity for the only other ehrlichial agent known to infect horses, probably because E. equi and E. risticii are not considered antigenically similar. 5 Antigenemia was detected prior to the development of clinical signs and before serum antibodies were measurable by ELISA and IFA methods, indicating the increased sensitivity of this antigen-detecting ELISA in the early phase of E. risticii infection over other serologic methods. However, the ehrlichial antigen titer did not persist in the plasma of 2 of 4 horses after an early increase. Similar regression of antigenemia was noted in the detection of malarial antigen in mice. 8 The disappearance of antigenemia may result from host antibodies binding the circulating antigens, making complexes that are either not detectable by the monoclonal antibody in ELISA or causing rapid clearance of antigen from blood. In a previous study utilizing Sources and manufacturers Western immunoblots to detect serum antibody response of E. risticii-infected horses, at least 3 different agnosis of E. risticii infection in horses; however, it may lack the sensitivity to detect all active infections. As the clinical disease progresses, the level of circulating antigenemia may decrease to undetectable levels in infected horses. A more direct method of detecting parasitemia in Potomac horse fever that would not be hindered directly by host antibody response is the polymerase chain reaction procedure to detect segments of the E. risticii genome. A detectable level of antigenemia occurs in E. risticii infection, suggesting that blood is an appropriate specimen for genetic methods for diagnosis of Potomac horse fever.
